Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 156


Primary pulmonary synovial sarcoma: A reappraisal.

Panigrahi MK, Pradhan G, Sahoo N, Mishra P, Patra S, Mohapatra PR.

J Cancer Res Ther. 2018 Apr-Jun;14(3):481-489. doi: 10.4103/0973-1482.204883.


Primary pleuropulmonary and mediastinal synovial sarcoma: a clinicopathologic and molecular study of 26 genetically confirmed cases in the largest institution of southwest China.

Lan T, Chen H, Xiong B, Zhou T, Peng R, Chen M, Ye F, Yao J, He X, Wang Y, Zhang H.

Diagn Pathol. 2016 Jul 11;11(1):62. doi: 10.1186/s13000-016-0513-3.


Histology and grading are important prognostic factors in synovial sarcoma.

Bianchi G, Sambri A, Righi A, Dei Tos AP, Picci P, Donati D.

Eur J Surg Oncol. 2017 Sep;43(9):1733-1739. doi: 10.1016/j.ejso.2017.05.020. Epub 2017 May 25.


Recurrent and novel SS18-SSX fusion transcripts in synovial sarcoma: description of three new cases.

Przybyl J, Sciot R, Rutkowski P, Siedlecki JA, Vanspauwen V, Samson I, Debiec-Rychter M.

Tumour Biol. 2012 Dec;33(6):2245-53. doi: 10.1007/s13277-012-0486-0. Epub 2012 Sep 14.


Synovial sarcoma: defining features and diagnostic evolution.

Thway K, Fisher C.

Ann Diagn Pathol. 2014 Dec;18(6):369-80. doi: 10.1016/j.anndiagpath.2014.09.002. Epub 2014 Oct 13. Review.


Primary intrathoracic synovial sarcoma: a clinicopathologic study of 40 t(X;18)-positive cases from the French Sarcoma Group and the Mesopath Group.

Bégueret H, Galateau-Salle F, Guillou L, Chetaille B, Brambilla E, Vignaud JM, Terrier P, Groussard O, Coindre JM.

Am J Surg Pathol. 2005 Mar;29(3):339-46.


Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients.

Ladanyi M, Antonescu CR, Leung DH, Woodruff JM, Kawai A, Healey JH, Brennan MF, Bridge JA, Neff JR, Barr FG, Goldsmith JD, Brooks JS, Goldblum JR, Ali SZ, Shipley J, Cooper CS, Fisher C, Skytting B, Larsson O.

Cancer Res. 2002 Jan 1;62(1):135-40.


Synovial Sarcoma With Myoid Differentiation.

Qassid O, Ali A, Thway K.

Int J Surg Pathol. 2016 Sep;24(6):525-7. doi: 10.1177/1066896916645187. Epub 2016 Apr 22.


Synovial sarcoma showing loss of a green signal in SS18 fluorescence in situ hybridization: a clinicopathological and molecular study of 12 cases.

Jiang D, Peng R, Yan X, Chen M, Lan T, Chen H, Zhang Z, Jing W, Jiang L, Ma L, Zhang H.

Virchows Arch. 2017 Dec;471(6):799-807. doi: 10.1007/s00428-017-2211-2. Epub 2017 Jul 31.


The impact of chromosomal translocation locus and fusion oncogene coding sequence in synovial sarcomagenesis.

Jones KB, Barrott JJ, Xie M, Haldar M, Jin H, Zhu JF, Monument MJ, Mosbruger TL, Langer EM, Randall RL, Wilson RK, Cairns BR, Ding L, Capecchi MR.

Oncogene. 2016 Sep 22;35(38):5021-32. doi: 10.1038/onc.2016.38. Epub 2016 Mar 7.


SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma.

Kawai A, Woodruff J, Healey JH, Brennan MF, Antonescu CR, Ladanyi M.

N Engl J Med. 1998 Jan 15;338(3):153-60.


Detection of SS18-SSX fusion transcripts in formalin-fixed paraffin-embedded neoplasms: analysis of conventional RT-PCR, qRT-PCR and dual color FISH as diagnostic tools for synovial sarcoma.

Amary MF, Berisha F, Bernardi Fdel C, Herbert A, James M, Reis-Filho JS, Fisher C, Nicholson AG, Tirabosco R, Diss TC, Flanagan AM.

Mod Pathol. 2007 Apr;20(4):482-96. Epub 2007 Mar 2.


Deflection of vascular endothelial growth factor action by SS18-SSX and composite vascular endothelial growth factor- and chemokine (C-X-C motif) receptor 4-targeted therapy in synovial sarcoma.

Wakamatsu T, Naka N, Sasagawa S, Tanaka T, Takenaka S, Araki N, Ueda T, Nishizawa Y, Yoshikawa H, Itoh K.

Cancer Sci. 2014 Sep;105(9):1124-34. doi: 10.1111/cas.12469. Epub 2014 Sep 3.


Strong association of SYT-SSX fusion type and morphologic epithelial differentiation in synovial sarcoma.

Antonescu CR, Kawai A, Leung DH, Lonardo F, Woodruff JM, Healey JH, Ladanyi M.

Diagn Mol Pathol. 2000 Mar;9(1):1-8.


A novel fusion gene, SS18L1/SSX1, in synovial sarcoma.

Storlazzi CT, Mertens F, Mandahl N, Gisselsson D, Isaksson M, Gustafson P, Domanski HA, Panagopoulos I.

Genes Chromosomes Cancer. 2003 Jun;37(2):195-200.


Truncated SSX protein suppresses synovial sarcoma cell proliferation by inhibiting the localization of SS18-SSX fusion protein.

Yoneda Y, Ito S, Kunisada T, Morimoto Y, Kanzaki H, Yoshida A, Shimizu K, Ozaki T, Ouchida M.

PLoS One. 2013 Oct 9;8(10):e77564. doi: 10.1371/journal.pone.0077564. eCollection 2013.


[Detection of SYT-SSX fusion gene in paraffin-embedded tissues and its clinicopathologic significance for synovial sarcoma].

Wei Y, Sun M, Zhu H, Xu Z, Wang J, Zhu X.

Zhonghua Bing Li Xue Za Zhi. 2001 Dec;30(6):426-30. Chinese.


SYT-SSX fusion genes in synovial sarcoma of the thorax.

Yano M, Toyooka S, Tsukuda K, Dote H, Morimoto Y, Ohata N, Ichimura K, Aoe M, Date H, Shimizu N.

Lung Cancer. 2004 Jun;44(3):391-7. Review.


Detection of the synovial sarcoma translocation t(X;18) (SYT;SSX) in paraffin-embedded tissues using reverse transcriptase-polymerase chain reaction: a reliable and powerful diagnostic tool for pathologists. A molecular analysis of 221 mesenchymal tumors fixed in different fixatives.

Guillou L, Coindre J, Gallagher G, Terrier P, Gebhard S, de Saint Aubain Somerhausen N, Michels J, Jundt G, Vince DR, Collin F, Trassard M, Le Doussal V, Benhattar J.

Hum Pathol. 2001 Jan;32(1):105-12.


Supplemental Content

Support Center